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The ability to detect low concentrations of biomarkers in patient samples is one of the
cornerstones of modern healthcare. In general, biosensing approaches are based on mea-
suring signals resulting from the interaction of a large ensemble of molecules with the sensor.
Here, we report a biosensor platform using DNA origami featuring a central cavity with
a target-specific DNA aptamer coupled with a nanopore read-out to enable individual bio-
marker detection. We show that the modulation of the ion current through the nanopore
upon the DNA origami translocation strongly depends on the presence of the biomarker in
the cavity. We exploit this to generate a biosensing platform with a limit of detection of 3 nM
and capable of the detection of human C-reactive protein (CRP) in clinically relevant fluids.
Future development of this approach may enable multiplexed biomarker detection by using
ribbons of DNA origami with integrated barcoding.
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Rapid and low-cost detection of disease biomarkers isbecoming increasingly important in modern healthcarewhere a growing focus is placed on early diagnosis1–4. This
presents considerable technological challenges as the relevant
biomarkers are often present at very small concentrations. Ideally,
a diagnostic assay should be able to detect the presence of few
biomarkers in a small volume of a complex clinical sample. The
currently employed clinical diagnostic assays are generally based
on ensemble-averaging immunoassays such as enzyme-linked
immunosorbent assays (ELISAs). In these, an antibody or anti-
body mimetic is used to capture relevant biomarkers in the sample,
and in general, each antibody–biomarker interaction contributes a
small amount to the accumulated assay signal. However, the
individual immuno-interactions cannot be identified anymore and
only manifest themselves as part of this ensemble-averaged signal.
Arguably, the ability to detect biomarkers with single entity reso-
lution rather than via ensemble-averaging techniques provides
significant advantages for the detection of ultra-small biomarker
concentrations.
Of the many single molecule methods which have been
developed over recent years5–10, the use of nanopores, where a
voltage is applied across the nanopore and pulses in the time-
varying electrochemical current are used for detecting individual
proteins11–16, is a promising approach. Here, single molecules
translocate through the nanoscale pore causing a momentary
modulation in the otherwise steady ion current17. This approach
has been employed in a number of single-molecule protein and
DNA detection studies18–22.
However, despite these advances, there remain significant
challenges. It is very difficult to detect a specific molecule from
a complex mixture as the translocation speed of single entities is
generally high when the diameter of the nanopore is much
larger than the size of the molecule, and the translocation
therefore results in only a weak signal, and correspondingly
low signal-to-noise. Furthermore, the signals resulting from
different proteins are generally very similar and difficult to
differentiate. To address these limitations, a variety of strategies
have been implemented, including slowing down protein
translocations through careful selection of electrolytes23,24 and
developing high-bandwidth electronics25,26. Also, chemical
and biological modification of nanopores27,28 and the use of
hybrid nanopores29 have been explored to increase sensitivity
and selectivity. More recently, large carrier molecules including
nanoparticles11, antibodies13 and very promisingly long linear
dsDNA29–33 and the entire genome of the lambda bacterioph-
age14 have been exploited both to host the protein of interest
and to reduce the translocation speed.
While DNA-based carriers have been used successfully and
indeed provide a useful carrier system owing to the ease of
modifying and engineering the system, the long linear DNA
carriers are not without limitations – they are prone to forming
knots and kinks34 which are known to lead to false positive
signals during nanopore translocation. Furthermore, significant
variations in the signal have been noted, depending on the
translocation and orientation, as well as high blockage rates due
to the simultaneous passage of multiple DNA molecules
through the nanopore35,36. In an approach to circumvent these
problems, recent work by Cai et al.32 combined single-molecule
fluorescence with nanopore detection to perform single-
molecule binding assays. Their approach, although elegant,
negates the key advantage of nanopore sensing by introducing
labelling and complex optical setups as opposed to a simple
electrical label-free read-out.
An alternative approach to long linear DNA carriers is to form
a carrier molecule by folding up a long DNA into a defined robust
geometry which can then host the subject molecule, in an
analogous approach to that used to study single biological reac-
tions with high speed atomic force microscopy37. These large
robust DNA nanostructures, referred to as DNA origami38,
provide a versatile carrier platform to circumvent the limitations
of linear DNA-based approaches. Importantly, our previous work
has demonstrated that single 2D DNA origami can be detected
using nanopores and that their translocations yield different ion
current signatures depending on their geometries39.
Here we exploit rationally designed 2D DNA origami
nanostructures for quantitative single-molecule biosensing. We
demonstrate that DNA aptamer-functionalized DNA origami
can capture the analyte of interest and that the occupied and
unoccupied DNA origami’s translocation fingerprints are
readily distinguishable. We demonstrate that in addition to the
characteristically different peak shape, also the peak amplitude
and dwell time can be used to distinguish occupied from
unoccupied carriers. Taken together, this enables quantitative
biosensing via counting of individual occupied DNA origami
carriers, which we demonstrate in physiological solutions and
diluted human plasma.
Results
Concentric squares. In a previous study we showed that the ion
current fingerprint of 2D DNA origami upon translocation
through a nanopore depends on their geometries39. In particular,
we found that the presence of a cavity in the centre of the origami
led to the splitting of the peak in the ion current into a double
peak. Here, we hypothesise that if a DNA origami is designed to
contain a cavity in the centre into which an analyte of interest can
bind specifically, the presence or absence of the analyte from the
origami can be detected using a nanopore by observing the
characteristic translocation ion current peak. The frequencies of
the two characteristically different peaks can be computed from
the observation of a large number of individual peaks to obtain an
analyte concentration-dependent signal.
To gain further insight into the design parameters of the cavity
in the 2D DNA origami governing the transition from single to
double-peak, we designed three different DNA nanostructures
with identical outer but variable cavity dimensions. The three
DNA nanostructures resemble a set of three concentric squares
and are referred to as ConA for a solid nanostructure (100 nm ×
85 nm), ConB and ConC for a nanostructure of identical outer
dimension but containing a central cavity of 30 nm × 12 nm and
65 nm × 25 nm, respectively, as shown in Fig. 1a.
The concentric square nanostructures were all designed to
be folded according to established DNA origami principles.
The three DNA tiles were made from the same constituents, i.e.,
the same oligonucleotide staples and identical scaffold routing,
with the varying cavity dimensions achieved by shortening the
underlying DNA scaffold. For example, the scaffold DNA used
to assemble ConB was the same as the one used for assembling
ConA but with the section that folds the central part removed.
This approach ensures that as much of the structure as possible
remained identical between the different DNA origamis while
varying the cavity dimension so we can directly correlate the
ion current signature to the cavity volume. The detailed
procedure for custom scaffold design and production as well
as the routing map are provided in Supplementary information
(Supplementary Fig. 11a–d).
The folded DNA nanostructures were imaged with Atomic
Force Microscopy (AFM) to confirm successful assembly.
Representative AFM images are shown in Fig. 1b and it can
be seen that all three structures were formed as intended.
Not unexpectedly, the measured dimensions of the three tiles
(all averaged over 30 tiles) differ slightly from the designs. The
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outer dimensions of all tiles were found to be 107 nm × 86 nm,
and ConB and ConC with a cavity of 29 nm × 11 nm and
65 nm × 38 nm, respectively.
To carry out nanopore translocation studies for the
concentric square samples, we employed glass nanopipettes
with ~100 nm pore diameter (Supplementary Fig. 10a, b).
The nanopipettes were fabricated via laser pulling and showed a
resistance of 86 ± 10 MΩ in 0.1 M KCl. Translocation experi-
ments were carried out by loading a sample solution at a
concentration of 500 pM into the nanopipette and recording
the ion current under a voltage of –350 mV.
Figure 1c shows representative ion current signatures for the
different nanostructures translocating through the nanopore. As
expected, as a cavity is introduced in the nanostructure the
observed peak structure changes from a single peak (no cavity
present) to a double peak (cavity present), with the double peak
becoming more pronounced (double peak height of 37 pA for
ConC vs 14 pA for ConB, Supplementary Fig. 2) with increasing
cavity size. A detailed quantitative analysis of more than 100 ion
current peaks for each DNA nanostructure shows that the average
peak amplitude and dwell time differ significantly for different
nanostructures (Supplementary Fig. 1).
ConC (large cavity) translocates through the nanopore
significantly slower (dwell time= 0.31 ± 0.14 ms) and leads to a
smaller ion current increase (peak amplitude= 86 ± 19 pA) when
compared to ConB (small cavity; dwell time= 0.22 ± 0.06 ms and
peak amplitude= 97 ± 13 pA). In contrast, ConA (no cavity)
nanostructure causes the largest ion current increase (peak
amplitude= 121 ± 23 pA) with the shortest dwell time (0.15 ±
0.01 ms). It is possible that these differences in peak amplitude
and dwell time could represent the combined contribution of the
overall charge and geometry of the DNA nanostructures due to
the variable scaffold length used in these designs. It is, however,
notable that the distinct ion current signatures consistently
correlate with the cavity geometry, both in this study as well as
our previous study on different tiles with cavities39. When taken
together, these parameters allow the identification of distinct
populations of DNA nanostructures (Fig. 1d).
DNA nanostructures as translocation carriers in biosensing.
The relationship of ion current peak signature to cavity geo-
metry within these DNA nanostructures provides a unique
opportunity to detect the presence of a much smaller molecule.
If a binding moiety specific to the target molecule of interest is
placed within the cavity of the DNA nanostructure, the binding
of a target molecule to the binding moiety partially fills the
cavity which in turn results in a characteristic change to the ion
current signature (Fig. 2a).
As proof of principle, we demonstrate the quantitative
detection of human C-reactive protein (CRP), which is an
established inflammation biomarker. In a healthy adult the
median CRP concentration is 0.8 µg/mL, and its concentration in
blood exceed 1 mg/mL (8 μM)40 as a result of an inflammatory
response. CRP exists as a pentamer with a molecular weight of
~125 kDa and a size of ~11 nm (Supplementary Fig. 5). We
designed a DNA nanostructure with a central cavity large enough
for a CRP molecule to fit in but at the same time small enough
such that the presence of CRP in the cavity will make a
measurable difference to the translocation ion current. As
informed by the study with concentric squares, the nanostructure
was designed with a central cavity of 35 nm × 35 nm to provide a
robust double peak signature (Fig. 2b).
An internal anchor stub was introduced within the central
cavity such that a specific capture moiety can be placed inside the
cavity via DNA hybridisation (Fig. 2b). In order to enable selective
CRP detection, we chose two well-characterised CRP-DNA
aptamers (aptamer 1 and aptamer 2) from the literature41–43 as
potential capture moieties. We note that while the sequences of
the DNA aptamers employed here are the same as the ones
published, for this application the aptamers have to be extended at
their 5′ or 3′ end, respectively, so they can be hybridised into the
cavity. To ensure the DNA aptamers are still performing as
intended, we confirmed CRP binding to the extended aptamers by
surface plasmon resonance (SPR). As shown in Supplementary
Fig. 3, both DNA aptamers continue to bind CRP as expected.
Aptamer 1 showed faster binding kinetics compared to aptamer 2
and hence was selected for the detailed demonstration of the
biosensor concept.
A notch was also included at one corner of the DNA origami to
act as a polarity marker to identify the orientation of the origami
in AFM images (Fig. 2b). The complete DNA nanostructure and
aptamer assembly is henceforth referred to as the carrier.
The performance of the DNA aptamer within the context of
the carrier (i.e. aptamer hybridised within the DNA nanos-
tructure, Fig. 2b) was investigated by gel retardation assay.
A 9 nM solution of the carrier was incubated with increasing
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Fig. 1 Concentric square DNA origami nanostructures. a Colour-coded schematic representation of DNA nanostructure designs – ConA is a solid tile and
ConB and ConC are frame-like with different central cavities. All three structures feature similar external dimensions but varying internal cavity. b AFM
micrographs of the respective nanostructures and c their typical translocation ion current signatures. d Scatter plot of individual translocation events with
peak amplitude plotted versus dwell time for ConA (blue circles), ConB (green circles) and ConC (black circles), overlaid with the respective 95%
confidence ellipses. Source data are in the Source Data file.
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concentrations of CRP (9, 18, 27 and 36 nM) in the
translocation buffer (0.1 M KCl containing 10 mM MgAc,
2 mM CaCl2, 10 mM TrisAc and 1 mM EDTA) at room
temperature for 30 min. The gel is shown in Fig. S4, and a
concentration-dependent shift of the carrier bands can be seen
which demonstrates successful CRP binding to the carrier. CRP
(36 nM) binding to the carrier (9 nM) was further confirmed by
AFM under similar buffer conditions as stated above (Fig. 2b),
where the CPR is clearly observed in the cavity bound to the
aptamer which is opposite the inbuilt polarity marker.
To exploit the DNA nanostructure carrier in single-molecule
nanopore sensing, the occupied and unoccupied carriers need to
have unique fingerprints (composed of dwell time, amplitude and
shape of the ion current peak) which relate to the presence of
CRP within the carrier. Nanopore translocation studies of the
carriers (at 500 pM concentration) using glass nanopipettes were
carried out as above. The quantitative analysis of more than 100
translocation peaks reveals a peak amplitude of 65 ± 6 pA and
dwell time of 0.29 ± 0.1 ms (Fig. 2c, top) which are comparable
with previous observations of similar-sized DNA nanostructures
containing cavities39.
Similarly, to analyse the CRP-occupied carriers we used an
equimolar solution of CRP and carriers at 9 nM with the aim of
having a mixed population of occupied and unoccupied carriers.
The solution was incubated at room temperature for 30 min in
the translocation buffer and subjected to nanopipette transloca-
tion at 500 pM concentration, which led to a mixed population of
single and double peaks in the ion current. The analysis of the
peak amplitudes and dwell times of the two classes of peaks
revealed a bipolar distribution. The double peaks had an average
peak amplitude of 62 ± 4 pA and dwell time of 0.33 ± 0.03 ms
(Fig. 2c, bottom; n > 100). In contrast, the analysis of more than
50 single peaks revealed an average dwell time and peak
amplitude of 0.15 ± 0.05 ms and 90 ± 9 pA, respectively, which
demonstrates a substantial shift in both quantities as a result of
CRP binding (Fig. 2c, bottom). We note that the lower peak
amplitude and the longer dwell time are very similar to the ones
observed for the unoccupied carriers.
Together with the results of the concentric squares study which
showed that the peak shape changes from a double peak to a
single peak upon filling in the central cavity, we speculate that the
single peak events correspond to occupied carriers, i.e., carriers
with a CRP bound to the specific aptamer. Furthermore, the
double peaks are accounting for ~30% of the total number of
observed events. This is in line with the percentage of occupied
carriers that would be expected based on the Kd obtained from
the SPR experiments (Supplementary Fig. 3d), which suggests
that the percentage is concentration dependent as expected.
However, in order to use this approach for high-sensitivity
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Fig. 2 DNA origami carrier-based biosensors. a Schematic representation of the DNA nanostructure-based biosensing concept exploiting translocation
through nanopipettes as the sensing mechanism. b Schematic representation of the design and representative AFM micrographs of the unoccupied and
occupied DNA origami carriers. The frame DNA nanostructure is ~95 nm × 95 nm in dimension with a 35 nm × 35 nm inner cavity. The DNA origami
comprises small nucleotide ‘anchors’ that protrude into the cavity which facilitate the incorporation of the DNA aptamer via hybridisation. The DNA carrier
also includes a polarity marker. c Peak amplitude and dwell time histograms of DNA nanostructure carriers (9 nM) and carriers incubated with CRP at 9 nM
concentration, both measured at a final carrier concentration of 500 pM. d Typical ion current signatures upon translocation of CRP molecules, CRP–DNA
aptamer complexes, unoccupied carriers and CRP-bound occupied carriers. The scale bars represent 20 pA and 1 ms, respectively. Source data are in the
Source Data file.
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events is required. Supplementary Fig. 6a(i) shows the scatter
plots of the peak amplitudes versus dwell times of the ion current
peaks observed for the translocation of unoccupied carriers.
All events which resemble the shape of double peaks are shown in
orange, and all other events as black triangles, indicating that they
cannot be classified. To eliminate outliers and to ensure robust
classification, ion current events will only be classified as a true
double peak representing an unoccupied carrier (indicated by
orange circles) if the measured peak amplitude and dwell time fall
within the 95% confidence ellipse, which is indicated in the figure.
Peaks which fall outside of this boundary are indicated by orange
triangles and will not be considered as events representing
unoccupied carriers.
Similarly, Supplementary Fig. 6a(ii) shows the scatter plots of
the peak amplitudes versus dwell times of the ion current events
observed for the translocation of carriers incubated with ten times
excess of CRP expected to lead to the majority of carriers being
occupied. All events which resemble the shape of double peaks
and single peaks are shown in orange and blue, respectively, and
all other events as black triangles, indicating that they cannot be
classified. As above, to ensure a robust classification for single
peaks to represent CRP-occupied carriers, the 95% confidence
ellipse (indicated as a blue ellipse) is employed as an in-out filter.
Only single peaks which fall within this 95% confidence area are
considered as resulting from the translocation of a CRP-occupied
carrier (indicated by blue circles), all other single peaks are
considered unclassified (indicated by blue triangles). To classify
the double peaks, and thereby establishing the number of events
representing unoccupied carriers, the confidence ellipse from
panel (i) is indicated in orange, and now only double-peak events
which fall within this area are considered as representing
unoccupied carriers (orange circles), while the ones outside this
area are dismissed (orange triangles).
This now enables the classification of observed ion current peaks
into three categories – double peaks representing unoccupied
carriers, single peaks representing CRP-occupied carriers, and
unclassified peaks which resemble neither a double nor a single
peak. This multi-parameter classification allows the discarding of
ambiguous translocation events, for example resulting from broken
carriers, in a robust way. Such events would likely resemble single
peaks and hence represent false positives. To illustrate this, the
DNA nanostructures were deliberately disrupted by incubation in
10mM CaCl2 for 30min to substitute the constituent Mg2+ with
Ca2+ prior to translocation. The AFM micrographs in Supple-
mentary Fig. 6b panel (i) demonstrate that the carriers have been
degraded significantly. During the translocation experiments only
very few events were recorded, and the peak amplitude vs dwell
time scatter plot shows that none of the recorded peaks fall within
the relevant confidence ellipse (panels (ii) and (iii) of Supplemen-
tary Fig. 6b), demonstrating the robustness of the classification
approach. As such, the counting of false positives from broken or
truncated carriers in the sample is limited effectively by the filtering
of the single peaks via the classification procedure discussed above.
We note that the small concentration of Ca2+ in the translocation
buffer does not affect the carriers significantly. Even after
incubation of the carriers for 4 h in the translocation buffer, only
a small number (~10%) of the translocation events would be
classified as CRP-occupied carries with the above classification
method (Supplementary Fig. 6c).
Importantly, due to the large dimensions of the nanopipette
pore (100 nm) compared to the diameter of CRP (11 nm; Fig. S5),
the translocation of CRP alone does not lead to a detectable ion
current signature and hence cannot be detected by our
nanopipette sensor (Fig. 2d). Similarly, any other molecules in
the solution, including linear DNA which have been used as
carriers in previous single-molecule sensing14,32 (Supplementary
Fig. 7a), would also not lead to any signals, thereby neither
contributing noise nor false negatives or positives.
Quantitative single-molecule biosensing. To demonstrate
quantitative sensing using the translocation of carriers with spe-
cific DNA aptamers, and the concept of counting individual
carrier molecules classified through the three-parameter approach
(peak amplitude, dwell time, and shape), we analysed the ion
currents of a range of translocation experiments at different CRP
concentrations (Supplementary Fig. 7b).
Figure 3a shows a collection of representative ion current
peaks for a range of different CRP concentrations. For each
concentration, the observed ion current events were classified as
described above (Fig. 3b and Supplementary Fig. 7c). Where
single or double peaks did not satisfy the filtering criteria
they were marked as ‘unclassified’ and were not taken into
account for the concentration analysis. Such unclassified peaks
represented between 9 and 36% of the total number of events in
a 2-min trace.
Figure 3c shows the normalised single peak count, i.e., classified
single peaks vs total number of classified peaks, for different
concentrations of CRP from 3 nM to 90 nM. As expected, the
normalised single peak count increases with increasing CRP
concentration. The data were fitted with a Langmuir isotherm,
using the dissociation constant Kd as the only fitting parameter, and
the result is shown as a solid line. The Kd obtained from the fit is
11 ± 2 nM, which is of the same order of magnitude as the results
from our SPR study of DNA aptamer 1.
To investigate the specificity of our sensing system, and in
particular of the carriers to the CRP target, a random DNA
sequence was selected to act as a non-specific aptamer and the
translocation ion current was measured for carrier concentra-
tion of 9 nM and CRP concentration of 90 nM, i.e., the highest
concentration reported in Fig. 3. The analysis of the ion current
events is shown in Fig. S8. A single distribution of peak
amplitudes and dwell times with averages of 69 ± 5 pA and
0.3 ± 13 ms, respectively, were found consistent with the values
measured with unoccupied carriers. The scatter plot clearly
shows that only double peaks were identified, and no single
peaks, demonstrating that a non-specific aptamer does not lead
to any detection signal.
Furthermore, the CRP-specific carrier (at a 9-nM concentra-
tion) was subjected to 90 nM of a control protein of similar size as
CRP (MupB), and the results of the ion current analysis is shown
in Figure S8. Similar to the non-specific aptamer, single
distributions of dwell time and peak amplitudes (averages of
0.25 ± 0.1 ms and 60 ± 7 pA) were observed which are in line with
those for unoccupied carriers. The scatter plot clearly shows that
no single peaks were identified (n > 50) demonstrating that no
MupB bound to the CRP-carriers.
Using the three-parameter classification (amplitude, dwell
time, and ion current signature) quantitative detection down to
3 nM CRP in ~5 µl sample volume was achieved within a 2-min
sampling window.
Importantly, a similar study but with a different CRP-specific
aptamer (aptamer 2) was carried out and the data is presented in
Supplementary Tables 5 and 6. The results are shown in
Supplementary Figs. 12 and 13 and very similar results to the
carrier version with CRP aptamer 1 were obtained, demonstrating
the robustness of the biosensing approach.
For applications in clinical diagnostics, it is important that
quantitative detection of analytes such as CRP can also be
performed in complex biological fluids. To demonstrate the
performance of our sensor system with such fluids, nanopipettes
were filled with a solution of 5% human plasma diluted in 0.1 M
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KCl and spiked with different concentrations of CRP ranging
from 3 nM to 36 nM. Similar to the situation in buffer, the
carriers in 5% plasma without CRP produced double peak ion
current events, but with a slightly shorter dwell time of 0.26 ±
0.10 ms and peak amplitude of 55 ± 6 pA (Fig. 4a, n > 50). In
contrast, the peak characteristics for occupied carriers, i.e., the
single peaks observed in 5% plasma spiked with CRP were found
to be consistent between experiments in 5% plasma (peak
amplitude 0.12 ± 0.04 ms and dwell time 98 ± 1 pA, n > 30, Fig. 4b)
and buffer (0.15 ± 0.05 ms and 90 ± 9 pA).
The different ion current events observed during a transloca-
tion experiment with 5% plasma can be classified into single
peaks, double peaks and unclassified peaks in the same way as in
buffer. Figure S9 shows the scatter plots for peak amplitude versus
dwell time for all CRP concentrations with the single and double
peaks which were selected as representing CRP-occupied and
unoccupied carriers, respectively, indicated in the same way as for
the buffer experiments.
The normalised single peak count, i.e., the ratio of single
peaks vs total classified peaks, is shown in Fig. 4c as a function
of CRP concentration. Similar to the results in buffer, the
normalised single peak count increases with CRP concentra-
tion, and follows a similar behaviour. The limit of detection is
estimated to be 9 nM (compared to 3 nM in pure buffer). We
note that the number of unclassified events observed for various
CRP concentrations in plasma samples were similar (9–25%) to
those observed in pure buffer.
Discussion
We have demonstrated a biosensing approach based on identi-
fying and counting individual biomarkers translocated through a
nanopore on a DNA origami carrier which features a central
cavity with a target-specific DNA aptamer.
To demonstrate the underlying concept, we have produced
three DNA nanostructures of identical outer dimension but fea-
turing central cavities of different sizes by generating customised
single-stranded scaffolds for DNA origami folding. We found that
upon translocation of these DNA nanostructures through the
100-nm pore of a glass nanopipette, the ion current through the
nanopore was modulated differently depending on the size of the
central cavity in the DNA origami. The origami with no central
cavity caused a single peak in the translocation ion current, while
both origami with central cavities led to double peaks, albeit with
different double-peak heights. Furthermore, the peak character-
istics, the peak amplitude and dwell time, were found to be sig-
nificantly different depending on the presence or absence, and in
fact the size, of a central cavity. Together, the three characteristics
– peak shape, amplitude and dwell time – provide a robust way to
differentiate between carriers with and without a cavity. This was
exploited to generate a biosensor platform for human CRP in
buffer and in diluted human plasma.
We designed DNA origami structures with central cavities large
enough to lead to a clearly identifiable double-peak in the trans-
location ion current, but small enough that if the biomarker of
interest – human CRP – is inserted into the cavity, the translocation
ion current peak becomes a single peak. To facilitate the specific and
selective binding of the biomarker of interest into the cavity, a
biomarker-specific DNA aptamer was weaved into the DNA ori-
gami structure on the edge of the cavity. Translocation studies with
unoccupied DNA origami carriers and highly CRP-occupied car-
riers revealed two distinct dwell-time – peak amplitude clusters,
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Fig. 3 CRP binding study. a Representative selection of ion current signatures for different CRP concentrations. The peak traces are stitched together from
individual peaks of a longer trace to remove regions with no events for the purpose of illustration. b Translocation events of carriers (9 nM) incubated with
different concentrations of CRP with their peak amplitude plotted against dwell time. The single peaks in the ion current data are coloured blue while the
double peaks are coloured orange, and the unclassified events discarded from the quantitative analysis are represented as triangles. The plots are overlaid
with the 95% confidence ellipses from Fig. S6a. c Normalised single peak count, i.e., ratio of single peaks vs total classified peaks against CRP concentration
(Supplementary Tables 1 and 2). The data were fitted with a Langmuir isotherm (solid line) and revealed a Kd of 11 ± 2 nM. The dashed lines represent the
confidence boundaries of the fit. The error bars denote the standard deviation of translocation experiments conducted on different days using three
different nanopipettes (n= 3). The sampling time was 2min for all concentrations. Source data are in the Source Data file.
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This ability to differentiate between biomarker-occupied and
unoccupied carriers provides solid foundations for biosensing.
Using the three-parameter classification, i.e., the peak shape
and the 95% confidence ellipse in the peak amplitude – dwell time
scatter plot, quantitative detection down to 3 nM and 9 nM CRP
in ~5 µl sample volume of buffer and diluted human plasma,
respectively, was achieved within a 2-min sampling window.
Using robustly folded rather than long linear DNA which is
often the carrier of choice for nanopore experiments, many of the
setbacks were overcome. The easily identifiable ion current sig-
nature of the DNA origami carrier not only minimises false
positives owing to knots and folds often occurring in linear DNA,
but also eliminates the ‘tail to head’ and ‘head to tail’ ambiguity
which is encountered with long linear DNA strands with respect
to its translocation direction.
Importantly, this carrier/nanopore biosensing approach is
based on counting individual biomarkers rather than relying on
an ensemble-averaged signal. As such, the sensitivity of this
system can be improved, for example, by reducing the size of the
confidence ellipses used to eliminate outliers and thus to increase
the stringency of the classification. This, in turn, would require an
extension of the sampling time to ensure statistically relevant
numbers of occupied and unoccupied carriers are recorded.
Furthermore, improving the DNA origami designs with increased
robustness will reduce the number of broken and thus unclassi-
fiable carriers in the sample, contributing to increased sensitivity
and specificity. Finally, the presented biosensing system has the
potential to be advanced to multiplexed detection, e.g., through
using ribbons of DNA origamis with integrated barcoding.
Methods
DNA origami design. The three concentric square origamis were designed using
the custom made single-stranded DNA (ssDNA) scaffolds of 9073 bp, 8515 bp and
6307 bp whereas the DNA nanostructures used as carriers in this project were
designed from 7249 bp m13mp18 ssDNA from Tillibit (Garching, Germany).
The procedure for custom made scaffolds is provided in the Supplementary
information. All short staple strands for the respective nanostructure designs were
purchased from IDT (Coralville, IA, USA).
All DNA origami nanostructures were designed using the caDNAno
2.3 software (the routing design for each nanostructure is included in
the Supplementary information, Supplementary Fig. 11d and Fig. 14) The source
data (caDNAno design files and oligo list) is provided along with this paper in the
data availability section. For the origami folding, a mixture of ssDNA scaffold with
a 10-fold molar excess of the staple strands in the folding buffer containing 10 mM
TrisAc (pH 7.4), 10 mMMgAc and 1mM EDTA (Sigma Aldrich, USA) was heated
to 95 °C and then cooled to room temperature with 1 °C/min. The folded structures
were purified by removal of excess staples via Sephacryl S400 (GE healthcare, UK)
size exclusion column and eluted into the same folding buffer.
The aptamer sequence containing a modified end sequence with 5′ (aptamer 1)
and 3′ (aptamer 2) amine attachment was incorporated into the carrier design in a
second thermal annealing step (heating up to 35 °C followed by decrease to room
temperature at 0.5 °C per minute) either in the presence of the staples before the
purification step, or alternatively immediately after the purification step. Either way
resulted in precisely folded frame DNA origami carriers inserted with an aptamer.











SPR study. Aptamer–protein binding studies were carried out via an ESPRIT SPR
instrument from Metrohm Autolab B.V (Utrecht, The Netherlands). For this, the
end-modified aptamers attached with an amine group were anchored onto the gold
SPR surface functionalized with a self-assembled monolayer (SAM) of C11PEG6-
COOH via EDC (1-ethyl-3-(3- dimethylaminopropyl) carbodiimide) NHS (N-
hydroxysuccinimide) coupling chemistry44. The gold SPR surface from XanTec
bioanalytics was cleaned by sonication twice in acetone for 10min and then immersed
in an ethanolic 1 mM SAM solution containing 5% acetic acid and allowed to stand at
room temperature for 48 h. Following the incubation, the surface was rinsed with
100% ethanol, quickly dried with nitrogen and mounted on the SPR system. To attach
the DNA aptamers to the gold surface, the COOH-terminated SAM surface was
activated with 50mM EDC and 200mM NHS in 100mM MES buffer at pH5.5 for
around 15min. The surface was washed with the MES buffer, followed by a 30-min
incubation with 5 µM of DNA aptamer in 10mM sodium acetate buffer at pH5.5.
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Fig. 4 CRP detection in diluted human plasma. Typical ion current traces, and peak amplitude and dwell time histograms for a unoccupied carriers and
b CRP-occupied carriers incubated in different concentrations of CRP in 5% plasma. c Normalised single peak count, i.e., ratio of single peaks vs total
classified peaks against CRP concentration (Supplementary Tables 3 and 4). The solid line is a guide to the eye. The error bars are standard deviation
calculated from three different traces (n= 3). The sampling time was 2min for all samples. Source data are in the Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18132-1 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4384 | https://doi.org/10.1038/s41467-020-18132-1 | www.nature.com/naturecommunications 7
Any remaining activated COOH sites were quenched by exposing the surface to 100
mM ethanolamine in water for ~10min. The surface was then washed with the
binding buffer (10mM TrisAc, 10mM MgAc, 2mM CaCl2 and 1mM EDTA in
water) and then challenged with varying concentration of human CRP. The binding
was measured as the change in resonance angle.
Nanopipette fabrication and ion current measurements. The nanopipettes with
100 nm diameters were fabricated from glass capillaries of 0.5 mm inner diameter
(QF100-50- 7.5, World precision Instruments, UK) using a Sutter instrument
model P-2000 laser puller. The pulling protocol comprised two separate lines with
the parameters HEAT 575 FIL 3 VEL 35 DEL 145 PULL 75 and HEAT 900 FIL 2
VEL 15 DEL 128 PULL 150. This protocol produced highly consistent glass
nanopipettes with a standard deviation of <±12 nm with nanopipettes pulled on
different days. An Ag/AgCl wire (0.25 mm diameter, Sigma Aldrich, UK) was
inserted into the nanopipettes as a working electrode.
For the translocation experiments the nanopipettes with the working electrode
were filled with the translocation buffer (0.1M KCl with 10mM TrisAc, 10mM
MgAc, 2mM CaCl2 and 1mM EDTA) containing the DNA origami and analyte
where applicable at a final concentration of 500 pM. The Mg is required to maintain
the stability of the DNA origami, and the Ca to match the buffer conditions used to
select the DNA aptamers employed as binding moieties. The grounded counter
electrode was immersed in a 0.1M KCl solution to complete the circuit. On
application of a negative potential to the working electrode inside the nanopipette,
DNA origami carriers from inside the nanopipette are translocated out into the
electrolyte solution resulting in a modulation of the ion current. Measurements were
recorded using the Axopatch 700b amplifier (Molecular devices, USA), and the data
were acquired at a rate of 100 kHz and 20 kHz low-pass filtered via the PClamp
10.6 software. Initial data analysis was carried out with a custom MATLAB script
(provided by Prof Joshua Edel, Imperial College, London, UK) using MATLAB 9.5
and further data analysis was carried out using proFit 7 (QuanSoft, Switzerland). The
raw data files are provided along with this paper in the data availability section.
AFM. DNA origami samples were deposited on freshly cleaved mica discs for
10–15mins at room temperature and topped up with scanning buffer containing
10mM TrisAc and 10mM MgAc. For observing protein binding to carriers, 2 mM
CaCl2 was included to the scanning buffer similar to the nanopipette translocation
experiments. The DNA origami samples were imaged using a Bruker Dimension
Fastscan (Santa Barbara, CA, USA) with Fastscan D Si3N4 cantilevers containing a Si
tip in tapping mode in liquid. Images were obtained with scan rates of 20 kHz (256 ×
256 pixels) via nanoscope 9.1 and analysed with nanoscope analysis 1.9 software.
Statistics and reproducibility. The AFM micrographs shown in the main text
Fig. 1b are representative images of successfully folded DNA origami concentric
square structures. A typical scan size of 1–2 μ was conducted at least three times for
each sample from independent folding experiments. Similarly, Fig. 2b contains
representative AFM images of CRP unoccupied and occupied carrier. AFM
experiments for carriers incubated with CRP were conducted at least three times
each on different days for both aptamer 1 and aptamer 2. Likewise, CRP micro-
graphs in Supplementary Fig. 5 were imaged on two different days, 10 micrographs
were collected each day. The gel retardation assay in Supplementary Fig. 4 was
conducted for carriers functionalised with aptamer 1 and aptamer 2 on different
days using carriers from different batches. Experimental results shown in micro-
graphs of Supplementray Fig. 6b, c were repeated twice on different days. And
Supplementary Fig. 7 shows the representative ion current traces of lambda DNA
translocation, these translocation experiments were repeated using three different
nanopipettes for each concentration (500 pM and 1 nM). Data for all the above
experiments is available via the data repository provided along with this paper.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data supporting this work can be freely accessed via the University of Leeds repository:
https://doi.org/10.5518/858. Source data is available in the Source Data file. Any other
relevant data are available from the authors upon reasonable request. Source data are
provided with this paper.
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